Cryptocurrencies
Cryptocurrencies
RankingCategoriesHistorical SnapshotsToken unlocksYieldReal-World Assets
Leaderboards
TrendingUpcomingRecently AddedGainers & LosersMost VisitedCommunity SentimentChain Ranking
Prediction Markets
TrendingNew CryptoPoliticsSportsFinanceTech
NFT
Overall NFT StatsUpcoming Sales
Dashboards
Markets
Market OverviewSpot MarketNo. of CryptocurrenciesBitcoin TreasuriesBNB TreasuriesExchange Inflows/Outflows
Indicators
Fear and Greed IndexAltcoin Season IndexMarket Cycle IndicatorsBitcoin DominanceCoinMarketCap 20 IndexCoinMarketCap 100 Index
ETF Flows
Crypto ETFsBitcoin ETFsEthereum ETFs
Technical Analysis
RSIMACD
Derivatives
OverviewLiquidationsFunding Rates
DexScan
SignalsNewTrendingNewGainersMeme ExplorerTop Traders
Exchanges
Centralized Exchanges
SpotDerivatives
Decentralized Exchanges
SpotDerivatives
Community
FeedsTopicsLivesArticlesSentiment
Products
Products
ConverterNewsletterCMC LaunchCMC LabsCMC MaxTop StoriesTelegram BotAdvertise
Crypto APISite Widgets
Learn
NewsAcademyResearchVideosGlossary
CMC AI
Ask CMC AIAI Alerts
Campaigns
AirdropsDiamond RewardsLearn & Earn
Calendars
ICO CalendarEvents Calendar

Novo Nordisk A/S stock price
NVO
#66

$39.38
  

0.13%

Novo Nordisk A/S Info

Market cap
$174.77B

0.13%

Daily Volume
$756.29M
Website
Asset type
Stocks
Employees
78387
Founded
Dec 21, 1923
Primary exchange
New York Stock Exchange
CIK number
0000353278

Tokenized Stock Data

Avg. Tokenized Price
$39.2
Price Difference
+$0.1829(-0.46%)
Tokenized Mkt Cap
$3.19M

3.71%

Tokenized Vol (24h)
$812.32K

3.06%

Issuers
Contracts
0x2815...B193E3
Explorers
NVO to USD converter
NVO
USD
Price Performance
Low
$37.89
High
$39.39

Loading Data

Please wait a moment.

Novo Nordisk A/S community

skeleton-white
 
 
 
 
 
 

About Novo Nordisk A/S

What is Novo Nordisk A/S?

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Popular Real World Assets

Gold
Gold
GOLD
$4,838.6
0.04%
Nvidia Corp
Nvidia Corp
NVDA
$195.9
0.28%
Silver
Silver
SILVER
$79.41
0.12%
Alphabet Inc Class A
Alphabet Inc Class A
GOOGL
$332.82
0.00%
Apple Inc.
Apple Inc.
AAPL
$258.56
0.09%
Microsoft Corp
Microsoft Corp
MSFT
$393.67
0.16%
Amazon.com Inc
Amazon.com Inc
AMZN
$248.93
0.03%
Taiwan Semiconductor Manufacturing Co Ltd
Taiwan Semiconductor Manufacturing Co Ltd
TSM
$383.62
0.98%
Broadcom Inc
Broadcom Inc
AVGO
$393.54
3.38%
Meta Platforms, Inc.
Meta Platforms, Inc.
META
$666.26
0.58%
Tesla, Inc.
Tesla, Inc.
TSLA
$364.74
0.15%
Berkshire Hathaway Inc.
Berkshire Hathaway Inc.
BRK.B
$477.91
0.08%
Walmart Inc
Walmart Inc
WMT
$124.8
0.19%
JPmorgan Chase & Co
JPmorgan Chase & Co
JPM
$310.96
0.05%
Eli Lilly And Co
Eli Lilly And Co
LLY
$924.98
0.25%
Exxon Mobil Corp
Exxon Mobil Corp
XOM
$148.9
0.21%
Visa Inc
Visa Inc
V
$311.35
0.01%
ASML Holding NV
ASML Holding NV
ASML
$1,528.57
0.72%
Johnson & Johnson
Johnson & Johnson
JNJ
$239.13
0.40%
Micron Technology Inc
Micron Technology Inc
MU
$459.58
1.28%

Novo Nordisk A/S Price Live Data

The current price of Novo Nordisk A/S in the market is $39.38, with a 24-hour trading volume of $756.29M. The asset's market cap is $174.77B, after moving 0.14% in the last day.

Tokenized Novo Nordisk A/S is trading at $39.2, with a tokenized market cap of $3.19M and a 24-hour trading volume of $812.32K. The tokenized asset has moved 3.71% in the past 24 hours.